Recently, stem cell-based therapies have been proposed as an alternative for the treatment
of many diseases. Stem cells (SCs) are well known for their capacity to preserve themselves …

Stem cells hold a great promise for the generation of new cell therapies for many currently
untreatable diseases, for human disease modeling or drug discovery. Many of these …

Human mesenchymal stem cells (hMSCs) have demonstrated great potential to be used as
therapies for many types of diseases. Due to their immunoprivileged status, allogeneic …

Production of human mesenchymal stem cells for allogeneic cell therapies requires
scalable, cost‐effective manufacturing processes. Microcarriers enable the culture of …

Due to their unique features, mesenchymal stem/stromal cells (MSC) have been exploited in
clinical settings as therapeutic candidates for the treatment of a variety of diseases …

The production of stem cells for clinical applications requires a suitable mass expansion and
harvest process, which is implemented in a microcarrier-based bioreactor. Important …

Mesenchymal stromal cells (MSC) are a promising platform for regenerative medicine
applications because of their multilineage differentiation abilities and ease of collection …

Microcarriers are synthetic particles used in bioreactor‐based cell manufacturing of
anchorage‐dependent cells to promote proliferation at efficient physical volumes, mainly by …

Human stem cells, including pluripotent, embryonic and mesenchymal, stem cells play
pivotal roles in cell-based therapies. Over the past decades, various methods for expansion …

Mesenchymal stem cells (MSCs) have emerged as an important tool for tissue engineering,
thanks to their differentiation potential and their broad trophic activities. However, for clinical …